Sector Update: Health Care Stocks Gain in Late Afternoon

MT Newswires Live06-22

Health care stocks gained late Friday afternoon with the NYSE Health Care Index up 0.2% and the Health Care Select Sector SPDR Fund (XLV) adding 0.3%.

The iShares Biotechnology ETF (IBB) rose 1.1%.

In corporate news, Iterum Therapeutics (ITRM) shares jumped 6.5% after the US Food and Drug Administration referred its new drug application for oral sulopenem to an advisory committee.

Lexicon Pharmaceuticals (LXRX) gained 6.6% after the company resubmitted its new drug application for sotagliflozin to supplement insulin therapy for people with type 1 diabetes and chronic kidney disease, following multiple consultations with the FDA.

Sharecare (SHCR) surged 76% after the company agreed to be acquired by an Altaris affiliate.

Sarepta Therapeutics (SRPT) received a label expansion from the FDA for Elevidys to treat ambulatory Duchenne muscular dystrophy, marking a "best-case scenario" and exceeding expectations, BofA Securities said in a report. BofA boosted Sarepta's price target to $213 from $166 and kept the buy rating. Analysts including RBC, Barclays, Oppenheimer and Baird also increased their price targets. Sarepta shares soared 31%.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2445779143?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-06-22 03:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2445779143","market":"hk","top_or_hot":-1,"title":"Sector Update: Health Care Stocks Gain in Late Afternoon","media":"MT Newswires Live","content":"<html><body><p> Health care stocks gained late Friday afternoon with the NYSE Health Care Index up 0.2% and the Health Care Select Sector SPDR Fund (XLV) adding 0.3%.</p><p>The <a href=\"https://laohu8.com/S/EEMA\">iShares</a> Biotechnology ETF (IBB) rose 1.1%.</p><p>In corporate news, Iterum <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (ITRM) shares jumped 6.5% after the US Food and Drug Administration referred its new drug application for oral sulopenem to an advisory committee.</p><p>Lexicon Pharmaceuticals (LXRX) gained 6.6% after the company resubmitted its new drug application for sotagliflozin to supplement insulin therapy for people with type 1 diabetes and chronic kidney disease, following multiple consultations with the FDA.</p><p>Sharecare (SHCR) surged 76% after the company agreed to be acquired by an Altaris affiliate.</p><p><a href=\"https://laohu8.com/S/SRPT\">Sarepta Therapeutics</a> (SRPT) received a label expansion from the FDA for Elevidys to treat ambulatory Duchenne muscular dystrophy, marking a \"best-case scenario\" and exceeding expectations, BofA Securities said in a report. BofA boosted Sarepta's price target to $213 from $166 and kept the buy rating. Analysts including RBC, Barclays, Oppenheimer and Baird also increased their price targets. Sarepta shares soared 31%.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sector Update: Health Care Stocks Gain in Late Afternoon</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSector Update: Health Care Stocks Gain in Late Afternoon\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-22 03:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Health care stocks gained late Friday afternoon with the NYSE Health Care Index up 0.2% and the Health Care Select Sector SPDR Fund (XLV) adding 0.3%.The iShares Biotechnology ETF (IBB) rose 1.1%.In ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2445779143","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2445779143","pubTimestamp":1718999585,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Health care stocks gained late Friday afternoon with the NYSE Health Care Index up 0.2% and the Health Care Select Sector SPDR Fund  adding 0.3%.The iShares Biotechnology ETF  rose 1.1%.In corporate news, Iterum Therapeutics  shares jumped 6.5% after the US Food and Drug Administration referred its new drug application for oral sulopenem to an advisory committee.Lexicon Pharmaceuticals  gained 6.6% after the company resubmitted its new drug application for sotagliflozin to supplement insulin therapy for people with type 1 diabetes and chronic kidney disease, following multiple consultations with the FDA.Sharecare  surged 76% after the company agreed to be acquired by an Altaris affiliate.Sarepta Therapeutics  received a label expansion from the FDA for Elevidys to treat ambulatory Duchenne muscular dystrophy, marking a \"best-case scenario\" and exceeding expectations, BofA Securities said in a report. BofA boosted Sarepta's price target to $213 from $166 and kept the buy rating. Analyst","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","SRPT":"Sarepta Therapeutics","BK4139":"生物科技","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","XLV":"健康照护类股ETF-SPDR","BK4167":"医疗保健技术","LXRX":"莱斯康制药","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","SHCR":"Sharecare Inc.","IBB":"生物科技指数ETF-iShares Nasdaq","ITRM":"Iterum Therapeutics Plc","BK4585":"ETF&股票定投概念","IE0002141913.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (USD) ACC","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","BK4581":"高盛持仓","IE00BJT1NW94.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (SGDHDG) ACC","BK4588":"碎股","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC"},"translate_title":"行业更新：医疗保健股午后上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XLV":1,"IBB":1,"SRPT":0.9,"SHCR":0.9,"LXRX":0.9,"ITRM":0.9},"content_text":"Health care stocks gained late Friday afternoon with the NYSE Health Care Index up 0.2% and the Health Care Select Sector SPDR Fund (XLV) adding 0.3%.The iShares Biotechnology ETF (IBB) rose 1.1%.In corporate news, Iterum Therapeutics (ITRM) shares jumped 6.5% after the US Food and Drug Administration referred its new drug application for oral sulopenem to an advisory committee.Lexicon Pharmaceuticals (LXRX) gained 6.6% after the company resubmitted its new drug application for sotagliflozin to supplement insulin therapy for people with type 1 diabetes and chronic kidney disease, following multiple consultations with the FDA.Sharecare (SHCR) surged 76% after the company agreed to be acquired by an Altaris affiliate.Sarepta Therapeutics (SRPT) received a label expansion from the FDA for Elevidys to treat ambulatory Duchenne muscular dystrophy, marking a \"best-case scenario\" and exceeding expectations, BofA Securities said in a report. BofA boosted Sarepta's price target to $213 from $166 and kept the buy rating. Analysts including RBC, Barclays, Oppenheimer and Baird also increased their price targets. Sarepta shares soared 31%.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2445779143"}